SEREX-analysis of three colon cancer cases

Experimental Oncology

Volumn 25, Issue 2, 2003, Pages 128-131

  Garifulin, O M ^a   Kykot, V O ^b   Gridina, N Y ^d   Kijamova, R G ^a   Gout, I T ^a,c   Filonenko, V V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^d Institute of Neurosurgery Ams of Ukraine   (Ukraine)

Author keywords

Antigen; Colon cancer; Humoral antibody response; SEREX; Serum

Indexed keywords

HUMORAL ANTIBODY; KY CC 1 ANTIGEN; KY CC 2 ANTIGEN; KY CC 21 ANTIGEN; KY CC 22 ANTIGEN; KY CC 3 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIBODY RESPONSE; ARTICLE; CASE REPORT; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; SEROLOGICAL ANALYSIS OF RECOMBINANT CDNA EXPRESSION LIBRARIES; DNA LIBRARY; IMMUNOREACTIVITY; SEROLOGY;

EID: 0041522591     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gelderman KA, Kuppen PJ, Bruin W, Fleuren GJ, Gorter A. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma. Eur J Immunol 2002; 32: 128-35.
2. Berinstein NL. Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J Clin Oncol 2002; 20: 2197-207.
3. Ritter G, Cohen LS, Williams CJr, Richards EC, Old LJ, Welt S. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. Cancer Res 2001; 61: 6851-9.
4. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-7.
5. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the atttologous host. Proc Natl Acad Sci USA 1995; 92: 11810-83.
6. Preuss KD, Zwick C, Bormann C, Neumann F, Pfreundschuh M. Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 2002; 188: 43-50.
7. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A, Meijer G. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002; 123: 1109-19.
8. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 484-7.
9. Jager D, Jager E, Knuth A. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J Clin Pathol 2001; 54: 669-74.
10. Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jager D, Jager E, Knuth A, Old LJ. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 2002; 62: 4041-7.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-9.
12. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998; 76: 652-8.
13. Libert F, Ruel J, Ludgate M, Swillens S, Alexander N, Vassart G, Dinsart C. Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. EMBO J 1987; 6: 4193-6.
14. Yamada K, Senju S, Nakatsura T, Murata Y, Ishihara M, Nakamura S, Ohno S, Negi A, Nishimura Y. Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun 2001; 280: 1169-76.
15. McDougall CJ, Ngoi SS, Goldman IS, Godwin T, Felix J, DeCosse JJ, Rigas B. Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res 1990; 50: 8023-7.
16. Warabi M, Kitagawa M, Hirokawa K. Loss of MHC class II expression is associated with a decrease of tumor-infiltrating T cells and an increase of metastatic potential of colorectal cancer: immunohistological and histopathological analyses as compared with normal colonic mucosa and adenomas. Pathol Res Pract 2000; 196: 807-15.
17. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32.
18. Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jager D, Jager E, Knuth A, Old LJ. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002; 98: 485-92.